| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-068-90 | 67877-068 | HUMAN PRESCRIPTION DRUG | Fesoterodine Fumarate | Fesoterodine Fumarate | TABLET, EXTENDED RELEASE | ORAL | 20220609 | N/A | ANDA | ANDA204827 | Ascend Laboratories, LLC | FESOTERODINE FUMARATE | 8 mg/1 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-068-90) |
| 67877-068-30 | 67877-068 | HUMAN PRESCRIPTION DRUG | Fesoterodine Fumarate | Fesoterodine Fumarate | TABLET, EXTENDED RELEASE | ORAL | 20220609 | N/A | ANDA | ANDA204827 | Ascend Laboratories, LLC | FESOTERODINE FUMARATE | 8 mg/1 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-068-30) |
| 67877-064-90 | 67877-064 | HUMAN PRESCRIPTION DRUG | Fesoterodine Fumarate | Fesoterodine Fumarate | TABLET, EXTENDED RELEASE | ORAL | 20220609 | N/A | ANDA | ANDA204827 | Ascend Laboratories, LLC | FESOTERODINE FUMARATE | 4 mg/1 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-064-90) |
| 67877-064-30 | 67877-064 | HUMAN PRESCRIPTION DRUG | Fesoterodine Fumarate | Fesoterodine Fumarate | TABLET, EXTENDED RELEASE | ORAL | 20220609 | N/A | ANDA | ANDA204827 | Ascend Laboratories, LLC | FESOTERODINE FUMARATE | 4 mg/1 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-064-30) |